152 related articles for article (PubMed ID: 22127490)
1. Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.
Nin JW; Ferreira I; Schalkwijk CG; Prins MH; Chaturvedi N; Fuller JH; Stehouwer CD;
Eur J Endocrinol; 2012 Feb; 166(2):325-32. PubMed ID: 22127490
[TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Peeters SA; Engelen L; Buijs J; Chaturvedi N; Fuller JH; Schalkwijk CG; Stehouwer CD;
Cardiovasc Diabetol; 2015 Mar; 14():31. PubMed ID: 25848912
[TBL] [Abstract][Full Text] [Related]
4. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
[TBL] [Abstract][Full Text] [Related]
5. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
Nin JW; Ferreira I; Schalkwijk CG; Jorsal A; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054
[TBL] [Abstract][Full Text] [Related]
6. Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.
Theilade S; Lajer M; Hansen TW; Rossing P
Acta Diabetol; 2014 Dec; 51(6):973-80. PubMed ID: 25274394
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
9. Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients.
Soedamah-Muthu SS; Chaturvedi N; Schalkwijk CG; Stehouwer CD; Ebeling P; Fuller JH;
J Diabetes Complications; 2006; 20(3):188-95. PubMed ID: 16632240
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetes.
Doggen K; Nobels F; Scheen AJ; Van Crombrugge P; Van Casteren V; Mathieu C
J Diabetes Complications; 2013; 27(4):370-5. PubMed ID: 23537603
[TBL] [Abstract][Full Text] [Related]
11. Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study.
Bellini S; Guarrera S; Matullo G; Schalkwijk C; Stehouwer CD; Chaturvedi N; Soedamah-Muthu SS; Barutta F; Gruden G
J Clin Endocrinol Metab; 2023 Dec; 109(1):e163-e174. PubMed ID: 37552780
[TBL] [Abstract][Full Text] [Related]
12. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study.
Schram MT; Chaturvedi N; Fuller JH; Stehouwer CD;
J Hypertens; 2003 Nov; 21(11):2035-44. PubMed ID: 14597846
[TBL] [Abstract][Full Text] [Related]
13. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study.
van Bussel BC; Soedamah-Muthu SS; Henry RM; Schalkwijk CG; Ferreira I; Chaturvedi N; Toeller M; Fuller JH; Stehouwer CD;
Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):758-64. PubMed ID: 22795869
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.
Nin JW; Ferreira I; Schalkwijk CG; Prins MH; Chaturvedi N; Fuller JH; Stehouwer CD;
Diabetologia; 2009 Apr; 52(4):705-14. PubMed ID: 19183936
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
Grauslund J; Nybo M; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
[TBL] [Abstract][Full Text] [Related]
16. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.
Yan XX; Lu L; Peng WH; Wang LJ; Zhang Q; Zhang RY; Chen QJ; Shen WF
Atherosclerosis; 2009 Aug; 205(2):544-8. PubMed ID: 19150066
[TBL] [Abstract][Full Text] [Related]
17. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
Liu JJ; Tavintharan S; Yeoh LY; Sum CF; Ng XW; Pek SL; Lee SB; Tang WE; Lim SC;
Diabet Med; 2014 Oct; 31(10):1199-204. PubMed ID: 24702136
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).
Soedamah-Muthu SS; Chaturvedi N; Pickup JC; Fuller JH;
Diabetologia; 2008 Mar; 51(3):493-501. PubMed ID: 18183363
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.
Koivisto VA; Stevens LK; Mattock M; Ebeling P; Muggeo M; Stephenson J; Idzior-Walus B
Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621
[TBL] [Abstract][Full Text] [Related]
20. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
Diabetes; 2010 Aug; 59(8):2027-32. PubMed ID: 20522598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
